MedTrace Logo

The Efficiency of Telemedicine to Optimize Metabolic Control in Patients With Diabetes in Turkey

NCT04789798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2021-03-11

No results posted yet for this study

Summary

The direct and indirect costs of treating diabetes are high. 10-15% of the health budgets of many countries are spent on diabetes treatment. Most of these expenses are due to the treatment and follow-up costs of complications seen in patients who are not well monitored and whose metabolic control is not achieved. the rapid increase in diabetes causes polyclinic and hospital services to become more intense. Despite the increasing number of patients, both performance and due to non-physician occupational groups' insufficiency (Diabetes Dietician, Diabetes Nurse), patients can only be given an appointment once a year, and patients cannot be allocated sufficient time during the appointment. Since these problems are valid worldwide, Telemedicine programs are designed to provide easy, cheap, and practical follow-up and treatment of many chronic diseases in various states of the USA and many developed European countries.

Conditions

  • Telemedicine
  • Telehealth

Interventions

DEVICE

TeleDiab (Telemedicine)

TeleDiab program components consist of: 1. Electronic transmission of capillary blood glucose measurement results 2. Electronic transmission of blood pressure measurements 3. Synchronized video-conferencing, secure messaging 4. Access to clinical data from patient files when necessary 5. Reminding of routine follow-up tests and examinations 6. Providing web-based educational materials to patients.

OTHER

Usual care

Usual diabetes care, as provided by primary care providers

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-21
Primary Completion
2015-10-19
Completion
2015-10-19

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04789798 on ClinicalTrials.gov